In:
Cancer, Wiley, Vol. 120, No. 5 ( 2014-03), p. 738-743
Abstract:
To the authors' knowledge, the current study is the first prospective trial of aromatase inhibition in patients with advanced uterine leiomyosarcoma. Letrozole met protocol‐defined criteria as an agent with activity in patients with advanced uterine leiomyosarcoma.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
Language:
English
Publisher:
Wiley
Publication Date:
2014
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1